MSH6 and colorectal carcinoma: MLH1 (3.33%, 74/2,181), MSH2 (2.83%, 63/2,181), and MSH6 (2.21%, 49/2,181) genes from the MMR pathway were the most frequently mutated genes in CRC patients.